Brief: Morepen Laboratories Gets License To Manufacture Hydroxychloroquine At Its Baddi Plant
20/04/2020 13:42
April 20 (Reuters) - Morepen Laboratories Ltd MORL.NS :
* GOT LICENSE TO MANUFACTURE HYDROXYCHLOROQUINE LAST WEEK
FOR ITS
BADDI PLANT IN HIMACHAL PRADESH
Source text for Eikon: ID:nBSEbnk07H
Further company coverage: MORL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Morepen Laboratories
See all newsBrief: Morepen Laboratories Says High Court Quashes Notice Seeking Recovery Of 1.18 Billion Rupees
India's Morepen Laboratories gains on U.S. FDA submission for Sitagliptin tablets
Brief: Morepen Laboratories Submits First U.S. ANDA For Sitagliptin Tablets USP In Three Strengths
Brief: Morepen Laboratories Ltd June-Quarter Consol Net Profit 563.5 Million Rupees
India's Morepen Laboratories slips after quarterly profit fall